Corcept Therapeutics financials at a glance

Year Year 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Rev. Revenue
$0.00M $0.00M $0.29M $0.48M $0.21M $0.03M $0.00M $0.00M $3.31M $10.36M $26.55M $50.29M $81.32M $159.20M $251.25M $306.49M $353.87M $365.98M $401.86M $482.38M $0.00M
GM % Gross Margin %
0.00% 0.00% 100.00% 100.00% 100.00% 100.00% 0.00% 0.00% 97.25% 98.62% 96.68% 97.29% 97.47% 97.77% 97.92% 98.20% 98.42% 98.56% 98.66% 98.66% 0.00%
OM Operating Margin
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -104.02% -6.85% 12.52% 33.20% 35.62% 36.41% 36.23% 34.01% 28.03% 22.24% 0.00%
EPS Earnings Per Share
$-0.89 $-1.09 $-0.34 $-0.43 $-0.38 $-0.38 $-0.39 $-0.33 $-0.36 $-0.22 $0.51 $0.85 $1.09 $1.17 $1.19 $0.87 $0.94 $0.00
Div. Dividends
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
PR % Payout Ratio %
0 0 0 0 0 0 0 0 -0.00% -0.00% -0.00% 0 0 0.00% 0.00% 0.00% 0.00% 0.00% 0 0 0
Sha. Shares
22.69m 22.7m 22.73m 39.55m 48.88m 62.47m 72.38m 84.23m 99.81m 99.81m 101.19m 108.78m 111.03m 114.12m 115.47m 114.28m 116.17m 105.93m 105.96m 103.08m 103.52m
OCF Operating Cash Flow
$-13.72M $-17.23M $-23.24M $-10.96M $-18.36M $-17.97M $-22.29M $-27.40M $-36.02M $-37.06M $-27.38M $3.13M $18.39M $60.94M $115.67M $136.12M $151.97M $167.89M $120.32M $127.04M $0.00M
FCF Free Cash Flow
$0.00M $0.00M $0.00M $0.00M $-18.37M $0.00M $-22.29M $-27.43M $-36.17M $-37.19M $-27.55M $-2.80M $18.37M $60.52M $115.37M $135.03M $150.71M $167.42M $119.91M $163.31M $0.00M
FCFS Free Cash Flow Per Share
$-0.74 $-0.76 $-1.02 $-0.32 $-0.39 $-0.34 $-0.33 $-0.33 $-0.39 $-0.37 $-0.27 $0.03 $0.16 $0.53 $1.00 $1.18 $1.31 $1.45 $1.12 $1.23 $0.00